Immunogenicity and Safety of Influenza Vaccine in Inflammatory Bowel Disease Patients Treated or not with Immunomodulators and/or Biologics: A Two-year Prospective Study

Journal of Crohn's & colitis

Volumn 9, Issue 12, 2015, Pages 1096-1107

  Launay, Odile ^a   Abitbol, Vered ^a   Krivine, Anne ^a   Slama, Lilia B en ^a   Bourreille, Arnaud ^b   Dupas, Jean L ouis ^a   Hébuterne, Xavier ^a   Savoye, Guillaume ^a   Deplanque, Dominique ^a   Bouhnik, Yoram ^a   Pelletier, Anne L aure ^a   Galtier, Florence ^a   Laharie, David ^a   Nachury, Maria ^a   Zerbib, Frank ^a   Allez, Mathieu ^a   Bommelaer, Gilles ^a   Duclos, Bernard ^a   Lucht, Frederic ^a   Gougeon, Marie Lise ^b   Tartour, Eric ^a   Rozenberg, Flore ^a   Hanslik, Thomas ^b   Beaugerie, Laurent ^a   Carrat, Fabrice ^a   more..

^a HÔPITAL SAINT ANTOINE   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

anti TNF; safety; Vaccine immune response

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; CLINICAL TRIAL; COMBINATION DRUG THERAPY; FEMALE; FOLLOW UP; HEMAGGLUTINATION INHIBITION TEST; HUMAN; IMMUNOLOGY; INFLAMMATORY BOWEL DISEASES; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA, HUMAN; MALE; MIDDLE AGED; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; PROSPECTIVE STUDY; TREATMENT OUTCOME; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84987667591     PISSN: None     EISSN: 18764479     Source Type: Journal    
DOI: 10.1093/ecco-jcc/jjv152     Document Type: Article

References (0)